Skip to main content
Premium Trial:

Request an Annual Quote

Abbott Labs, Compugen Work Together In mRNA Database Project

NEW YORK, Jan. 15-Abbott Laboratories and Compugen will work together to create a comprehensive human mRNA database, the two companies said today.

 

In this deal, Abbott has secured a license to LEADS, Compugen's computational biology platform. Working together, the two companies will use the platform to model genes, mRNA transcripts, and other genomic information. Abbott will use this data and public data from Compugen's Gencarta system to select new drug targets.

 

Financial details of the deal were not revealed.

 

For further information, see the press release.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.